Ralf Regenthal

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Topics

Transcranial Magnetic Stimulation

Vascular Smooth Muscle Cells

Major Depressive Disorder

Top Venues

Human brain mapping

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, Yuanyuan Gong, Michael Schaefer, Ralf Regenthal, Ute Krügel
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS. International journal of molecular sciences 23 (7) (2022)
Christian Schinke, Michael Rullmann, Julia Luthardt, Mandy Drabe, Elisa Preller, Georg A Becker, Marianne Patt, Ralf Regenthal, Franziska Zientek, Osama Sabri, Florian Then Bergh, Swen Hesse
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls. Brain sciences 12 (11) (2022)
Michael Rode, Kolja Nenoff, Kerstin Wirkner, Katrin Horn, Andrej Teren, Ralf Regenthal, Markus Loeffler, Joachim Thiery, Achim Aigner, Janne Pott, Holger Kirsten, Markus Scholz
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers. PloS one 17 (4) (2022)
Frank H Hezemans, Noham Wolpe, Claire O'Callaghan, Rong Ye, Catarina Rua, P Simon Jones, Alexander G Murley, Negin Holland, Ralf Regenthal, Kamen A Tsvetanov, Roger A Barker, Caroline H Williams-Gray, Trevor W Robbins, Luca Passamonti, James B Rowe
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. PLoS computational biology 18 (5) (2022)
Frank Baumann, Theresa Paul, Susan Wassersleben, Ralf Regenthal, Dirk Enke, Achim Aigner
Characterization of Drug Release from Mesoporous SiO 2 -Based Membranes with Variable Pore Structure and Geometry. Pharmaceutics 14 (6) (2022)
Rachel G Zsido, Eóin N Molloy, Elena Cesnaite, Gergana Zheleva, Nathalie Beinhölzl, Ulrike Scharrer, Fabian A Piecha, Ralf Regenthal, Arno Villringer, Vadim V Nikulin, Julia Sacher
One-week escitalopram intake alters the excitation-inhibition balance in the healthy female brain. Human brain mapping 43 (6) (2022)
Eóin N Molloy, Rachel G Zsido, Fabian A Piecha, Nathalie Beinhölzl, Ulrike Scharrer, Gergana Zheleva, Ralf Regenthal, Bernhard Sehm, Vadim V Nikulin, Harald E Möller, Arno Villringer, Julia Sacher, Karsten Mueller
Decreased thalamo-cortico connectivity during an implicit sequence motor learning task and 7 days escitalopram intake. Scientific reports 11 (1) (2021)
Xiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz, Michael Schaefer, Hai-Yan Yin, Peter Brust, Ralf Regenthal, Ute Krügel
Validation of an LC-MS/MS Method to Quantify the New TRPC6 Inhibitor SH045 (Larixyl N-methylcarbamate) and Its Application in an Exploratory Pharmacokinetic Study in Mice. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Nikolina Skandali, James B Rowe, Valerie Voon, Julia B Deakin, Rudolf N Cardinal, Francesca Cormack, Luca Passamonti, William R Bevan-Jones, Ralf Regenthal, Samuel Robin Chamberlain, Trevor W Robbins, Barbara J Sahakian
Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43 (13) (2018)